Valuation : Medpace Holdings, Inc.

Market Cap 16.28B 14.04B 13.23B 12.05B 22.53B 1,538B 22.7B 157B 60.78B 786B 61.13B 59.79B 2,583B P/E 2026 *
33.2x
P/E 2027 * 30.4x
Enterprise Value 15.48B 13.35B 12.58B 11.46B 21.42B 1,462B 21.58B 149B 57.79B 747B 58.11B 56.84B 2,455B EV / Sales 2026 *
5.43x
EV / Sales 2027 * 4.96x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day+1.42%
1 week-4.67%
Current month-0.65%
1 month+2.94%
3 months+32.44%
6 months+29.00%
Current year+5.07%
1 week 581.78
Extreme 581.78
624.99
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%-4.67%+24.68%+122.61% 16.28B
+0.97%-0.75%+3.51%+17.79% 49.74B
-0.57%-3.29%+427.09%+518.46% 44.98B
+2.85%+1.19%+44.02%+19.80% 42.52B
+0.84%-3.73%+8.96%+76.62% 40.78B
-0.90%-1.74%+15.20%+48.44% 32.89B
+2.05%+6.09% - - 17.09B
+1.70%-0.05%+18.53%+28.09% 14.4B
+2.78%-2.10%+79.16%+41.42% 13.48B
+0.61%-4.37%-9.17%-37.54% 12.45B
Average +1.21%-2.63%+68.00%+92.85% 28.46B
Weighted average by Cap. +1.00%-2.34%+88.76%+120.58%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.32B 2.11B 3.95B 269B 3.98B 27.44B 10.65B 138B 10.71B 10.47B 452B 3.03B 2.61B 2.46B 2.24B 4.19B 286B 4.22B 29.12B 11.3B 146B 11.37B 11.12B 480B
Net income 503M 434M 408M 372M 696M 47.47B 701M 4.84B 1.88B 24.27B 1.89B 1.85B 79.73B 547M 472M 444M 405M 756M 51.63B 762M 5.26B 2.04B 26.4B 2.05B 2.01B 86.72B
Net Debt -802M -692M -652M -594M -1.11B -75.79B -1.12B -7.72B -3B -38.75B -3.01B -2.95B -127B -1.25B -1.08B -1.02B -927M -1.73B -118B -1.75B -12.05B -4.68B -60.48B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
02/09/26 $590.16 +1.19% 93,212
01/09/26 $583.21 -1.81% 179,867
31/08/26 $593.99 -1.11% 347,286
28/08/26 $600.65 -1.79% 186,917
27/08/26 $611.57 -1.21% 198,155
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
583.21USD
Average target price
581.83USD
Spread / Average Target
-0.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock